Critically ill patients often show abnormal thyroid hormone levels—low T3, high rT3, and low or normal T4—which are linked to how sick they are and predict a higher risk of death, especially when free T4 is also low.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review and meta-analysis of prospective cohort studies could definitively establish whether low T3 and FT4 levels independently predict mortality in critically ill adults after adjusting for illness severity, age, and comorbidities.
A systematic review and meta-analysis of all prospective cohort studies enrolling adult ICU patients with NTIS, excluding those with pre-existing thyroid disease, measuring serum T3, FT4, and rT3 within 24 hours of admission, and reporting all-cause mortality at 28 and 90 days, with adjustment for APACHE II/SOFA scores, age, and organ failure.
An RCT could determine whether administering T3 or T4 to critically ill patients with low hormone levels reduces mortality compared to placebo.
A multicenter, double-blind, placebo-controlled RCT of 1000+ adult ICU patients with NTIS (T3 < 0.6 ng/mL and FT4 < 0.7 ng/dL), randomized to receive intravenous T3 (10 mcg loading, then 5 mcg every 8h for 72h) or placebo, with primary outcome of 28-day all-cause mortality and secondary outcomes of ICU length of stay and organ failure-free days.
A prospective cohort study could confirm whether the degree of T3 suppression predicts mortality risk across different ICU populations, independent of illness severity scores.
A prospective cohort study enrolling 500 adult ICU patients across 5 centers, measuring serial T3, FT4, and rT3 daily for 7 days, adjusting for APACHE II, sepsis status, and renal function, and tracking 90-day mortality to determine if T3 nadir is an independent predictor.
A cross-sectional study could describe the prevalence and magnitude of NTIS hormone patterns in a single ICU population at a single time point.
A cross-sectional study measuring T3, FT4, rT3, and TSH in 200 consecutive ICU patients within 12 hours of admission, stratifying by diagnosis (sepsis, trauma, cardiac arrest) and reporting median hormone levels and correlation with SOFA score.
An expert opinion can summarize existing evidence but cannot establish whether NTIS is a cause or consequence of critical illness.
A narrative review synthesizing observational studies and case reports on NTIS patterns in ICU patients, as presented in this document.